Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...

F OR FIVE years biotech startups have been betting that psychedelic substances could be turned into real medicines. One of them may have hit the jackpot. On February 17th Compass ...

I took part in a 2012 psilocybin trial. What I’m seeing now horrifies me,” writes Erica Rex, author of the new book “Seeing What Is There.” ...

Researchers reported rapid, significant improvement in depression, with the benefits lasting for months after treatment.

The No. 1 best psychedelic rock song of the 1960s, according to Collider, is "The End" (1967) by the legendary American rock ...

Compass Pathways (CMPS) added ~20% in the premarket on Tuesday after the U.K.-based biotech announced that its psychedelic ...

A psychedelic compound found in the Amazonian hallucinogenic brew ayahuasca quickly curbed clinical depression sufferers’ ...

In a small clinical trial, a single dose of a psychedelic drug paired with psychotherapy produced rapid antidepressant ...

The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the ...

The right counselor can make a huge difference.

The idea isn’t brand new, but the work gives the debate a fresh jolt because it tests a concrete preparation method rather than leaning on vibes, metaphors, or modern wishful thinking. Coverage by ...